FDA Drug Application (021217) for EXALGO by MALLINCKRODT INC

Back to FDA Applications sponsored by MALLINCKRODT INC

Application Number021217
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage8MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEXALGO
Active IngredientHYDROMORPHONE HYDROCHLORIDE



Back to FDA Applications sponsored by MALLINCKRODT INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.